Evidence map›Paper›PMID 40610764›Full record

ArticleLeukemia2025

Autophagosome-lysosome mediated secretion of the thrombopoietin receptor is modulated by distinct driver mutations of myeloproliferative neoplasm.

Shayeri Chowdhury, Saurabh Shrivastva, Aditi Singh, Farmaanullah Ansari, Saadia Naseer, Anita Roy

Abstract read
In one paragraph

Article in Leukemia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shayeri ChowdhuryKusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi, India.
Saurabh ShrivastvaKusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi, India.
Aditi SinghKusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi, India.
Farmaanullah AnsariKusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi, India.
Saadia NaseerKusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi, India.
Anita RoyKusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi, India. anita.roy@bioschool.iitd.ac.in.ORCID 0000-0002-7297-2920

Funding

DBT India Alliance (Wellcome Trust/DBT India Alliance) IA/I/19/1/504285DST | Science and Engineering Research Board (SERB) CRG/2023/003853Wellcome Trust
6 · The paper itself

Abstract

The maintenance of the haematopoietic stem cells and the production of platelets thereof is acutely dependent upon the thrombopoietin receptor (TpoR). TpoR dimerizes in the presence of its ligand thrombopoietin leading to the activation of downstream JAK2-STAT signalling. Alternatively, the receptor dimerizes in the presence of activating mutations of JAK2 (JAK2 V617F), calreticulin or TpoR leading to myeloproliferation. These effects are dependent upon the surface expression of the receptor. TpoR is secreted through the Golgi-dependent pathway. Although, an unconventional autophagosome-lysosome mediated traffic has been postulated; questions remained whether the observed lysosomal localization was indicative of degradation or secretion. We fused the pH-sensitive FRET pair of TOLLES-YPet with TpoR (SRAI-TpoR) that showed FRET quenching at low pH environment of lysosomes. Using this construct, we demonstrated the presence of quenched SRAI-TpoR on the cell surface indicating that TpoR could indeed be secreted through low pH compartments. We further demonstrated that the lysosome-autophagosome-mediated secretion of TpoR was promoted by JAK2 V617F mutation, partially utilized by TpoR W515L but abrogated by calreticulin mutations. Finally, we showed that the lysosome-autophagosome mediated secretion was dependent upon Rab1A. Our study conclusively showed the unconventional traffic of TpoR and its modulation by the driver mutations causing myeloproliferation.

Indexed as

AutophagosomesLysosomesMutationMyeloproliferative DisordersReceptors, ThrombopoietinCalreticulinHumansJanus Kinase 2CalreticulinJAK2 protein, humanJanus Kinase 2Receptors, Thrombopoietin

Identifiers

PMID40610764
PMCPMC12380609

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.